Trademark: 90765924
Status Date
Thursday, June 15, 2023
Filing Date
Thursday, June 10, 2021
Abandoned Date
Tuesday, May 16, 2023
5 Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, placental-derived cells, umbilical cord cells, placental-derived T cells, chimeric antigen receptor (CAR) T cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
1 Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical research
Aug 18, 2023
Exparte Appeal Terminated
Aug 18, 2023
Exparte Appeal Dismissed As Moot
Jun 15, 2023
Abandonment Notice E-Mailed - Failure To Respond
Jun 15, 2023
Abandonment Notice Mailed - Failure To Respond
Jun 15, 2023
Abandonment - Failure To Respond Or Late Response
May 31, 2023
Assigned To Examiner
Feb 14, 2023
Notification Of Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action Written
Dec 16, 2022
Teas Request For Reconsideration Received
Dec 16, 2022
Ex Parte Appeal-Instituted
Dec 16, 2022
Jurisdiction Restored To Examining Attorney
Dec 16, 2022
Exparte Appeal Received At Ttab
Jun 16, 2022
Notification Of Final Refusal Emailed
Jun 16, 2022
Final Refusal E-Mailed
Jun 16, 2022
Final Refusal Written
Apr 13, 2022
Teas/Email Correspondence Entered
Apr 12, 2022
Correspondence Received In Law Office
Apr 12, 2022
Teas Response To Office Action Received
Mar 9, 2022
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Mar 8, 2022
Use Amendment Accepted
Mar 8, 2022
Notification Of Non-Final Action E-Mailed
Mar 8, 2022
Non-Final Action E-Mailed
Mar 8, 2022
Non-Final Action Written
Mar 1, 2022
Assigned To Examiner
Sep 2, 2021
Amendment To Use Processing Complete
Sep 2, 2021
Use Amendment Filed
Jun 15, 2021
Teas Amendment Of Use Received
Aug 30, 2021
New Application Office Supplied Data Entered
Jun 14, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
